217 related articles for article (PubMed ID: 18509704)
21. Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study.
Ibrahim SM; Mulcahy MF; Lewandowski RJ; Sato KT; Ryu RK; Masterson EJ; Newman SB; Benson A; Omary RA; Salem R
Cancer; 2008 Oct; 113(8):2119-28. PubMed ID: 18759346
[TBL] [Abstract][Full Text] [Related]
22. A first report of radioembolization for hepatic metastases from ocular melanoma.
Kennedy AS; Nutting C; Jakobs T; Cianni R; Notarianni E; Ofer A; Beny A; Dezarn WA
Cancer Invest; 2009 Jul; 27(6):682-90. PubMed ID: 19219675
[TBL] [Abstract][Full Text] [Related]
23. Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers.
Kennedy AS; Nutting C; Coldwell D; Gaiser J; Drachenberg C
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1552-63. PubMed ID: 15590187
[TBL] [Abstract][Full Text] [Related]
24. Changes in normal liver and spleen volume after radioembolization with (90)Y-resin microspheres in metastatic breast cancer patients: findings and clinical significance.
Paprottka PM; Schmidt GP; Trumm CG; Hoffmann RT; Reiser MF; Jakobs TF
Cardiovasc Intervent Radiol; 2011 Oct; 34(5):964-72. PubMed ID: 21748452
[TBL] [Abstract][Full Text] [Related]
25. Radioembolization as locoregional therapy of hepatic metastases in uveal melanoma patients.
Klingenstein A; Haug AR; Zech CJ; Schaller UC
Cardiovasc Intervent Radiol; 2013 Feb; 36(1):158-65. PubMed ID: 22526099
[TBL] [Abstract][Full Text] [Related]
26. Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma.
Sangro B; Bilbao JI; Boan J; Martinez-Cuesta A; Benito A; Rodriguez J; Panizo A; Gil B; Inarrairaegui M; Herrero I; Quiroga J; Prieto J
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):792-800. PubMed ID: 16904840
[TBL] [Abstract][Full Text] [Related]
27. Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres.
Mulcahy MF; Lewandowski RJ; Ibrahim SM; Sato KT; Ryu RK; Atassi B; Newman S; Talamonti M; Omary RA; Benson A; Salem R
Cancer; 2009 May; 115(9):1849-58. PubMed ID: 19267416
[TBL] [Abstract][Full Text] [Related]
28. Biliary sequelae following radioembolization with Yttrium-90 microspheres.
Atassi B; Bangash AK; Lewandowski RJ; Ibrahim S; Kulik L; Mulcahy MF; Murthy R; Ryu RK; Sato KT; Miller FH; Omary RA; Salem R
J Vasc Interv Radiol; 2008 May; 19(5):691-7. PubMed ID: 18440457
[TBL] [Abstract][Full Text] [Related]
29. Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging.
Buijs M; Kamel IR; Vossen JA; Georgiades CS; Hong K; Geschwind JF
J Vasc Interv Radiol; 2007 Aug; 18(8):957-63. PubMed ID: 17675611
[TBL] [Abstract][Full Text] [Related]
30. Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy.
Rühl R; Seidensticker M; Peters N; Mohnike K; Bornschein J; Schütte K; Amthauer H; Malfertheiner P; Pech M; Ricke J
Dig Dis; 2009; 27(2):189-99. PubMed ID: 19546558
[TBL] [Abstract][Full Text] [Related]
31. Feasibility of high activity rhenium-188-microsphere in hepatic radioembolization.
Liepe K; Brogsitter C; Leonhard J; Wunderlich G; Hliscs R; Pinkert J; Folprecht G; Kotzerke J
Jpn J Clin Oncol; 2007 Dec; 37(12):942-50. PubMed ID: 18094017
[TBL] [Abstract][Full Text] [Related]
32. A multicentric phase II clinical trial on intra-arterial hepatic radiotherapy with 90yttrium SIR-spheres in unresectable, colorectal liver metastases refractory to i.v. chemotherapy: preliminary results on toxicity and response rates.
Mancini R; Carpanese L; Sciuto R; Pizzi G; Golfieri R; Giampalma L; Cappelli A; Galaverni MC; Blotta A; Fiore F; Izzo F; Lastoria S; Mastro A; Di Marzo M; Cagol PP; Gasparini D; Geatti O; Bacchetti S; Pasqual E; Zeuli M; Paoletti G; Garufi C; Cosimelli M;
In Vivo; 2006; 20(6A):711-4. PubMed ID: 17203751
[TBL] [Abstract][Full Text] [Related]
33. Radiologic findings following Y90 radioembolization for primary liver malignancies.
Ibrahim SM; Nikolaidis P; Miller FH; Lewandowski RJ; Ryu RK; Sato KT; Senthilnathan S; Riaz A; Kulik L; Mulcahy MF; Omary RA; Salem R
Abdom Imaging; 2009; 34(5):566-81. PubMed ID: 18777189
[TBL] [Abstract][Full Text] [Related]
34. Role of functional magnetic resonance imaging in assessing metastatic leiomyosarcoma response to chemoembolization.
Vossen JA; Kamel IR; Buijs M; Liapi E; Georgiades CS; Hong K; Geschwind JF
J Comput Assist Tomogr; 2008; 32(3):347-52. PubMed ID: 18520535
[TBL] [Abstract][Full Text] [Related]
35. Yttrium-90 radioembolization of renal cell carcinoma metastatic to the liver.
Abdelmaksoud MH; Louie JD; Hwang GL; Kothary N; Minor DR; Sze DY
J Vasc Interv Radiol; 2012 Mar; 23(3):323-30.e1. PubMed ID: 22277275
[TBL] [Abstract][Full Text] [Related]
36. Radioembolization with yttrium microspheres for neuroendocrine tumour liver metastases.
Cao CQ; Yan TD; Bester L; Liauw W; Morris DL
Br J Surg; 2010 Apr; 97(4):537-43. PubMed ID: 20205229
[TBL] [Abstract][Full Text] [Related]
37. Liver lesion detection and characterization in patients with colorectal cancer: a comparison of low radiation dose non-enhanced PET/CT, contrast-enhanced PET/CT, and liver MRI.
Cantwell CP; Setty BN; Holalkere N; Sahani DV; Fischman AJ; Blake MA
J Comput Assist Tomogr; 2008; 32(5):738-44. PubMed ID: 18830103
[TBL] [Abstract][Full Text] [Related]
38. Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres.
Flamen P; Vanderlinden B; Delatte P; Ghanem G; Ameye L; Van Den Eynde M; Hendlisz A
Phys Med Biol; 2008 Nov; 53(22):6591-603. PubMed ID: 18978442
[TBL] [Abstract][Full Text] [Related]
39. Hepatocellular Carcinoma Tumor Dose Response After
Kappadath SC; Mikell J; Balagopal A; Baladandayuthapani V; Kaseb A; Mahvash A
Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):451-461. PubMed ID: 30191875
[TBL] [Abstract][Full Text] [Related]
40. Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival.
Salem R; Lewandowski RJ; Atassi B; Gordon SC; Gates VL; Barakat O; Sergie Z; Wong CY; Thurston KG
J Vasc Interv Radiol; 2005 Dec; 16(12):1627-39. PubMed ID: 16371529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
